Andrew Atz to Vasodilator Agents
This is a "connection" page, showing publications Andrew Atz has written about Vasodilator Agents.
Connection Strength
0.819
-
Functional pulmonary atresia in neonatal Marfan's syndrome: successful treatment with inhaled nitric oxide. Pediatr Cardiol. 2001 Nov-Dec; 22(6):525-6.
Score: 0.182
-
Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents. J Clin Pharmacol. 2019 12; 59(12):1606-1619.
Score: 0.154
-
Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. J Am Coll Cardiol. 1999 Mar; 33(3):813-9.
Score: 0.151
-
Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg. 1996 Dec; 62(6):1759-64.
Score: 0.129
-
Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis. Am J Cardiol. 1996 Feb 01; 77(4):316-9.
Score: 0.122
-
Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics. Am Heart J. 2002 Jan; 143(1):15-21.
Score: 0.046
-
Inhaled nitric oxide and heparin for infantile primary pulmonary hypertension. Lancet. 1998 Jun 06; 351(9117):1701.
Score: 0.036